Dominic Marasco
President of Endocrine Business UnitMr. Dominic Marasco, also known as Nick, RPh, serves as President of Endocrine Business Unit at MannKind Corporation since January 06, 2025. He serves as Chief Commercial Officer at Envision Pharma, Inc. since January 2023. He had been Chief Commercial Officer at BioAgilytix Labs, LLC since December 2019 until December 2022. Mr. Marasco served as Member of Scientific Advisory Board at Unicycive Therapeutics, Inc. He has executive experience in C-suite strategy development, commercial operations, strategic business development, alliance management and financial resourcing within the Pharmaceutical, Biotech and Medical Device industries. Just prior to joining BioAgilytix, he served as Executive Vice President, Global Business Development, Commercial at Syneos Health from February 2018 to December 2019, where he led the overall strategic direction of the global business development team for the commercial division both in the U. S. and internationally. He is an experienced global commercial leader with pharmaceutical, biotech and medical device industry experience. Having held several C-suite positions, he has a proven track record of successfully launching and growing products and solutions with a focus on driving profitable revenue growth, building and leading high-performing commercial organizations. He is responsible to lead the development of Envision's commercial-to-customer strategy while identifying new pathways to progression, with a focus on continuing its revenue growth and expanding its customer reach and solutions. He helps develop, lead and reinforce Envision's position as a technology-enabled commercialization, data analytics and integrated medical capabilities and solutions company. Another key part of his role is to implement a coordinated and integrated sales structure across Envision to reinforce its technology-enabled positioning. He was also previously Head of U. S. Sales for the Neuroscience Business Unit at Amgen, Inc. and prior to that Global Commercial Head, Amgen Biosimilars. Mr. Marasco has also held executive-level commercial and business development positions at Sandoz Biopharmaceuticals (a Novartis company) and Quintiles Translational Corporation. Mr. Marasco is a Member of the Health Policy and Management Executive Council at the Harvard T. H. Chan School of Public Health and is a University of Southern California Adjunct Associate Professor of Pharmaceuticals and Health Economics for the School of Pharmacy. He received his Bachelor of Science in Pharmacy from the Philadelphia College of Pharmacy, University of the Sciences in Philadelphia from 1992 to 1996 and is a registered pharmacist with a current active licensure. He studied in Pre-Pharmacy Studies, Pharmacy from University of Pittsburgh from 1990 to 1992 and Holy Name High School.
Positions
- Company NameMannKind CorporationStock CodeMNKDPositionPresident of Endocrine Business UnitColleagues
- MEMichael E. CastagnaCEO & Director
- JSJames S. ShannonIndependent Chairman
- CBChristopher B. PrentissChief Financial Officer
- DBDavid B. ThomsonExecutive VP, General Counsel & Secretary
- SAStuart A. TrossChief People & Workplace Officer
- KKKent KresaChairman Emeritus
- RJRonald J. ConsiglioIndependent Director
- ACAnthony C. HooperIndependent Director
